Newbridge Securities acted as sole book running manager for the offering.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on GANX:
- Gain Therapeutics announces common stock, warrants offering
- Buy Rating for Gain Therapeutics Driven by Accelerated Clinical Progress and Valuation Model
- Promising Developments and Strategic Advancements Propel Gain Therapeutics to ‘Buy’ Rating
- Positive Outlook for Gain Therapeutics Amid Promising Biomarker Developments and Clinical Trial Progress
- Gain Therapeutics Advances Phase 1b Parkinson’s Study